Related Experiment Video
Updated: Nov 28, 2025
07:09
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
11.8K
Fibrinogen and Fibrin.
Rustem I Litvinov1, Marlien Pieters2,3, Zelda de Lange-Loots4,5
1Department of Cell and Developmental Biology, University of Pennsylvania Perelman School of Medicine, 421 Curie Blvd, BRB II/III, Room 1116, Philadelphia, PA, 19104-6058, USA.
Sub-Cellular Biochemistry
|November 30, 2020
Summary
Fibrinogen transforms into fibrin, forming a blood clot scaffold crucial for hemostasis and thrombosis. Altered fibrin clot properties significantly impact bleeding disorders and thrombotic events.
Area of Science:
- Biochemistry
- Hematology
- Biophysics
Background:
- Fibrinogen is the most abundant coagulation factor in plasma.
- Its conversion to fibrin forms the clot scaffold for hemostasis and thrombosis.
- Fibrin clot structure dictates mechanical properties and functional outcomes.
Purpose of the Study:
- Describe fibrinogen's molecular structure.
- Explain fibrinogen-to-fibrin conversion.
- Detail fibrin's mechanical properties and structural origins.
- Provide evidence for altered fibrin clot properties in thrombosis and bleeding.
Main Methods:
- Molecular structure analysis of fibrinogen.
- Investigation of fibrin polymerization reactions.
- Assessment of fibrin clot mechanical properties.
- Correlation of fibrin structure with hemostasis and thrombosis.
Main Results:
- Fibrinogen is a large glycoprotein synthesized in the liver.
- Fibrin polymerization creates a 3D porous network with specific mechanical properties.
- These properties are vital for clot function in hemostasis and thrombosis.
- Altered fibrin clot properties are linked to bleeding and thrombotic diseases.
Conclusions:
- The structure and mechanical properties of fibrin clots are critical for their function.
- Dysfunctional fibrin clots contribute to pathological thrombosis and bleeding disorders.
Related Concept Videos
01:20Extrinsic and Intrinsic Pathways of Hemostasis
10.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.9K
01:16Clot Retraction and Fibrinolysis
7.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.8K
01:25Fibronectins Connect Cells with ECM
3.0K
Fibronectin is an adhesive glycoprotein present in the extracellular matrix of embryogenic and adult tissue. These molecules primarily aid in regulating cell motility and attachment. A fibronectin molecule is composed of two identical polypeptide chains attached to each other by a pair of disulfide bonds at the C-terminal.
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
3.0K
01:09Coagulation
8.9K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.9K
01:06Coagulation
747
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
747
00:55Fibrous Proteins
3.9K
Fibrous proteins are either long and narrow proteins or assemble to form long and thin structures. They contain repetitive units and usually consist of either alpha helices or beta sheets and, in rare cases, a mix of both. The amino acids in the primary structure often consist of repeating amino acid sequences. The role of fibrous proteins is primarily structural. Many are located in the extracellular matrix and are present in connective tissues to impart strength and joint mobility. They are...
3.9K